THE EFFECT OF HSP65 MYCOBACTERIUM TUBERCULOSIS ON THE VACCINATION TOWARDS AORTIC THICKNESS OF MICE THAT HAVE BEEN INDUCED ATHEROSCLEROSIS
Keywords:
Aortic thickness, atherosclerosis, HSP65 Mycobacterium tuberculosisAbstract
Background. Atherosclerosis is an inflammatory process of the blood vessels accompanied by immune activity which is signed by the enhancement of histopathologic. One of the protective proteins in the human artery wall expressed when there is endothelial stress is HSP60. HSP65 is an HSP60 homologous protein found in bacteria, such as Mycobacterium tuberculosis.
Objective. To determine the effect of HSP65 through aorta thickness of mice.
Methods. This research applied experimental study using post-test control group design in which subjects were divided into 5 groups. Each group consisted of 5 mice. Group I mice fed a diet normokolesterolemia (negative control), group II mice given atherogenic diet without vaccine (positive control), group III mice given atherogenic diet and 0,5μg accination, group IV mice were given atherogenic diet and 0,75μg vaccination, group V mice were given atherogenic diet and 1μg vaccination.
Results. There was a difference between the atherogenic diet and vaccination group (p <0.05). There was a significant decrease in aortic thickness of atherosclerosis mice with HSP65 vaccination dose 0,75µg (r= -0,449, p= 0,024).
Conclusion. HSP65 Mycobacterium tuberculosis vaccination can reduce the thickness of the aorta in mice induced atherosclerosis and the effective dose is 0.75 mg dose.
References
Hansson, G. K. Immune Mechanisms in Atherosclerosis. Journal of American Heart Association, Arterioscler Thromb Vasc Biol. 2001; 21: 1876 - 1890 doi: 10.1161/hq1201.100220.
Hansson, G.K. and Libby, P. The Immune Response in Atherosclerosis: A Double-edged Sword. Nature Reviews Immunology 2006. Vol.6:508-519.
Maron R., Sukhova G., Faria A.M., Hoffman E., Mach F., Libby P., et al. Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice. Circulation: 2002. 106:1708-1715.
Puijvelde G.H.M.van, Es T. van, Wanrooij E.J.A. van, Habets K.L.L., Vos P. de, Zee vander, et al. 2007. Induction of Oral Tolerance to HSP60 or an HSP-60 Peptide Activates T Cell Regulation and Reduces Atherosclerosis. Arterioscler Thromb Vasc Biol 27:2677-2683.
Marker T., Sell H., Zilleßen P., Glode A., Kriebel J., Ouwens D.M., et. al. Heat Shock Protein 60 as a Mediator of Adipose Tissue Inflammation and Insulin Resistance. Diabetes; 2012. Vol. 61.
Xu Q., Metzler B., Jahangiri M., and Mandal K. Molecular Chaperones and Heat Shock Proteins in Atherosclerosis. Am J Physiol Heart Circ Physiol; 2011. 302: H506 - H514.
Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart Disease and Stroke Statistics-Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation: 2008 117:E25E146.
Sherer Y and Shoenfeld Y. Mechanisms of Disease: Atherosclerosis in Autoimmune Disease. Nature Clinical Practice Rheumatology. 2006. Vol.2 No.2.
Lumongga, Fitriani. Atherosclerosis. USU Repository. 2007.
